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signaling was evaluated in transgenic Caenorhabditis elegans. Camu-camu residue was fractionated into low
and highmolecularweight fractions and used as treatments. Relative fold changes in gene expression in response
to camu-camu treatments were quantiﬁed using ﬂuorescence microscopy. Also, the neuroprotective effects of
camu-camu residue in experimentally induced neurodegeneration were evaluated in C. elegans models for
Alzheimer's disease (AD) and Parkinson's disease (PD). For AD, time to thermally induced Aβ1–42 aggregation
mediated paralysis was evaluated in transgenic C. elegans (CL4176). For PD, MPP+ induced neurodegeneration
was quantiﬁed by loss in motility due to paralysis. Results suggest a signiﬁcant upregulation expression of
superoxide dismutase (SOD-3 and SOD-4) and catalases (CTL-1; CTL-2; CTL-3) in response to treatment with
camu-camu residue, especiallywith the lowmolecularweight fraction. Furthermore, treatmentwith this fraction
signiﬁcantly extended the life span in C. elegans by 20% and delayed Aβ1–42 induced paralysis by 21%. Addition-
ally, treatment with camu-camu residue also abrogated MPP+ induced neurodegeneration for PD by 15–21%.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Camu-camu (Myrciaria dubia (H.B.K.) McVaugh) is an exotic tropical
fruit native to the Amazon region and it is one of the few Amazon fruits
that have been explored for commercial purposes. The camu-camu fruit
belongs to the group of the so-called super fruits and it is known by its
outstanding content of ascorbic acid and health-relevant ﬂavonoids
(Borges, Conceição, & Silveira, 2014; Akter, Oh, Eun, & Ahmed, 2011).
They are economically important to theAmazon region, because this ex-
otic fruit grows in low-value areas, which are generally inadequate for
the cultivation of other species (Rodrigues, Menezes, Cabral, Dornier,
& Reynes, 2001).
Because of its natural acidity, the camu-camu fruit is mainly con-
sumed after processed into juices, concentrates, and for the production
of vitamin C capsules. As a result, great volumes of residue, consisting
of seeds, peels and residual pulp that represent around 40% of the fruit
inweight, are generated (Rodrigues et al., 2001). Despite this,while sev-
eral studies have focused in investigating the properties of camu-camu
pulp (Gonçalves, Lellis-Santos, Curi, Lajolo, & Genovese, 2014; Fujita,
Borges, Correia, Franco, & Genovese, 2013), the bioactive potential and
biological effects of the residue remain understudied (Azevêdo, Fujita,
Oliveira, Genovese, & Correia, 2014; Fracassetti, Costa, Moulay, &Tomás-Barberán, 2013). For example, recent research have described
anti-obesogenic, anti-atherogenic anti-inﬂammatory and anti-genotoxic
effects of camu-camu fruit juice (Silva et al., 2012; Langley, Pergolizzi,
Taylor, & Ridgway, 2014; Nascimento, Boleti, Yuyama, & Lima, 2013);
however, the literature describing the potential health beneﬁts of
camu-camu residue are nonexistent. In addition, creating a low-waste
agribusiness where environmental-friendly techniques would take full
advantage of the entire fruit would be advantageous for the entire
productive chain (Moo-Huchin et al., 2015).
The use of invertebrate organisms, especially Caenorhabditis elegans,
as model systems to study biological processes on molecular and cellu-
lar levels in higher organismshas recently become a popular and impor-
tant research tool. C. elegans are attractive models because they are
inexpensive and easy to experimentally manipulate (Chakraborty,
Bornhorst, Nguyen, & Aschner, 2013). Additionally, they also have
a short life span and have a completely sequenced genome possessing
60–80% homology to human genes. Recently, C. elegans has been
employed as amodel to study the effect of bioactive chemicals fromnat-
ural products on evolutionarily conserved signaling pathways involved
in stress response, life span, neurodegeneration and developmental
biology (Keith, Amrit, Ratnappan, & Ghazi, 2014). Also, it has been suc-
cessfully applied to assess the neuroprotective effects of tropical fruit
extracts (Bezerra et al., 2014; Bonomo et al., 2014).
We have previously demonstrated that freeze dried andhot air dried
camu-camu residue, are rich sources of bioactive compounds, including
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(Azevêdo et al., 2014). Based on these results, our objective here was
to evaluate for theﬁrst time the effects of dried camu-camuon themod-
ulation of stress response in vivo in C. elegans model and investigate
their potential neuroprotective effects. The experimental results pre-
sented herewill help to clarify the biological value of the residue obtain-
ed from this understudied fruit of the Brazilian biodiversity.2. Material and methods
2.1. Dried camu-camu production
The fresh camu-camu residue (FR) was submitted hot air drying
(HAD) process at 50 °C and air velocity of 4 m/s (HAD50) (Azevêdo
et al., 2014). The drying experiments were conducted by spreading
the previously thawed camu-camu residue in 10–15mm thick uniform
layers on a perforated tray. The hot air dryer equipment was equipped
with centrifugal blower (5.5 hp and 3490 rpm, model 112 M, WEG,
Brazil) and the airﬂow crossed perpendicularly through the tray placed
at the center of the drying chamber, where the temperature was moni-
tored by digital thermocouples.2.2. Low (LMWF) and high (HMWF) molecular weight fractions
The low and highmolecular weight fractions of camu-camu powder
were prepared using a method described previously (Bezerra et al.,
2014). For the lowmolecularweight fraction, 5 g of camu-camupowder
was suspended in 100 ml of water in an Erlenmeyer ﬂask at 60 °C and
allowed to mix for 30 min at 250 rpm. The samples were then centri-
fuged at 4000 rpm at 10 °C for 15 min. The supernatant was ﬁltered
under vacuum using a Buchner funnel equipped with Whatman No. 1
ﬁlter paper. The ﬁltrate was mixed with acetone in 1:1 (v/v) ratio and
again centrifuged to precipitate soluble gums and ﬁbers in the extract.
The acetone in the supernatant was evaporated in a Rotavapor®
(Model RII, Buchi, Switzerland) at 60 °C for 5 min under vacuum. The
acetone free solution was ﬁlter-sterilized (Corning, North Bend, OH)
and labeled as LMWF-HAD50.
To prepare the high molecular weight fraction, the residue from the
ﬁlter paper was scraped with a spatula into an Erlenmeyer ﬂask and
combined with the sediment from centrifugation from previous step
above. To this, 66.6 ml of 4 N NaOH was added, and the mixture was
stirred for 30 min at 250 rpm on a magnetic stirrer. The mixture was
then centrifuged and vacuum ﬁltered as described above. The pH of
the ﬁltrate was adjusted immediately to 7.0 and ﬁlter-sterilized into a
sterile bottle labeled as HMWF-HAD50.Table 1
List of C. elegans strains included is the gene names with their human homolog.
Strain Transgene Gene Hu
N2 Wild Type N/A N/
GR1352 xrls87[daf-16alpha::GFP::DAF-16B + rol-6(su1006)]. DAF-16α::GFP Fo
CF1553 muls84 [pAD76(sod-3::GFP)] sod-3::GFP
(driven by sod-3)
Iro
LG326 gels7[skn-1b::GFP]. [skn-1b::GFP] Nu
tra
BC13632 sEx13632 [rCesF55H2.1::GFP + pCeh361] sod-4::gfp Co
GA800 wuls151[ctl-1 + ctl-2 + ctl-3 + myo-2::GFP] [ctl-1 + ctl-2 + ctl-3 +
myo-2::GFP]
Ca
CL2166 dvls19[pAF15(gst-4::GFP::NLS)] gst-4 Gl
CL4176 smg-1(cc5460l; dvls27 X.
dvls27X[pAF29(myo-3/A-Beta1-42/let UTR) +
pRF4(rol-6(su1006))]
ABeta42 Hu
a Origination: www.wormbase.org.2.3. Preparation of polar acid (PA), polar basic (PB) and polar neutral (PN)
fractions
TheLMWF-HAD50wassolvent fractionatedtoobtainthePA,PBandPN
fractions. ThepHof these extractswas adjusted to 9.6 using5%NaOHand
transferred to a separation funnel to which 100ml of ethyl acetate was
added to 100ml of the extracts. Themixturewas vigorously shaken and
allowed to restuntil aphase separationwasachieved. Thedenser aqueous
phasewaselutedout, and labeledasPAafter adjusting itspHto7using1N
HCl. To the lighter organic phase, 30ml ofHCl 5% (v/v)was addedand the
mixture was again vigorously shaken and allowed to rest as described
above. Thedenser aqueous fractionwaselutedout, and labeledasPBafter
adjusting its pH to7using1NNaOH. The remnantorganic fractionwas la-
beled as PN and, alongwith PA andPB,wasﬁlter sterilized and stored at
4 °Cuntil use.Using this procedure, the following fractionsPA-HAD50, PB-
HAD50andPN-HAD50wereobtained.
2.4. C. elegans strains and maintenance
Wild type and transgenic C. elegans strains (Table 1) carrying green
ﬂuorescent protein (gfp) or heat shock protein (hsp) promoter fusions
of different genes relevant were obtained from the Caenorhabditis
Genetics Center (CGC) (University of Minnesota, Minneapolis, MN).
Worms were grown and maintained at 20 °C (except CL4176 which
was maintained at 16 °C) on 60 mm culture plates with Nematode
Growth Medium (NGM) (1.7% agar, 0.3% NaCl, 0.25% Peptone, 1 mM
CaCl, 1 mM MgSO4, 5 mg/l cholesterol, 2.5 mM KPO4 at 16–20 °C,
Brenner, 1974). Media was poured aseptically into culture plates (10 ml
for 60 mm) using a peristaltic pump and allowed to solidify for 36 h.
NGM culture plates were then inoculated with 50 μl of Escherichia coli
OP50 (CGC,University ofMinnesota,Minneapolis,MN)overnight cultures
and incubated for 8 h at 37 °C. Strains of C. elegans were maintained by
picking 2–3 young adult worms onto freshly inoculated NGM plates
every 4–7 days.
2.5. Age synchronization
Prior to the beginning of the experiment C. elegans were age syn-
chronized. Ten worms at L4 stage (F0) were transferred to single NGM
plates and incubated at 20 °C until they progressed to adulthood and
laid eggs. Adults were immediately removed from the plates and the
eggs were allowed to hatch (F1) and grow to L4 at 20 °C. L4 worms of
F1 generation were again transferred to fresh NGM plates and allowed
to mature into gravid adults and lay eggs at 20 °C. Adults were quickly
removed from the plates and were returned to 20 °C incubator to facil-
itate egg hatching. L1 worms (F2) generation were collected from
the plate by washing with S-basal buffer (0.59% NaCl, 5% 1 M KPO4,man homolog Wormbase gene IDa
A N/A
rkhead Box O (FOXO) WBGene00000912
n/manganese superoxide dismutase WBGene00004932
clear factor-erythroid-2 related factor-2 (Nrf2)
nscription factor
WBGene000004802
pper/zinc superoxide dismutase WBGene00004933
talase (ctl-1, ctl-2 e ctl-3) WBGene00000830, WBGene00000831,
WBGene00013220 respectively
utathione-requiring prostaglandin D synthase WBGene00001752
man amyloid β1–42 WBGene00003515
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Liu, 2013) into a sterile 15 ml centrifuge tube. Worms from a minimum
of 5 plates were pooled into a single centrifuge tube and centrifuged at
8000 rpm for 10 min at 10 °C. The supernatant was carefully aspirated
and the worms were washed again in by S-basal buffer, centrifuged and
aspirated to leave approximately 1 ml of S-basal in the centrifuge tube.
The tube was gently agitated to disperse the worms and 20 μl was pipet-
ted onto a slide and the number ofwormswas countedunder a stereomi-
croscope. The concentration of the worms was adjusted to be 10–15
worms bydilutingwith S-complete liquidmedia (97.7% S-basal, 1% potas-
sium citrate, 1% trace metals, 0.3% CaCl2, 0.3% MgSO4). A 100 mg/ml sus-
pension of E. coli OP50 was prepared by centrifuging 100 ml of an
overnight E. coli OP50 culture in LB at 3500 rpm. Spent LB was aspirated
and pellet was washed several times by resuspension and centrifugation
in sterile distilled water. The weight of the resultant pellet was deter-
mined and adjusted to 100 mg/ml using S-complete medium. E. coli
OP50 was added to the vial of age synchronized worms to yield a ﬁnal
concentration of 5 mg/ml and used immediately to set up experiments.
2.6. In vivo gene expression studies in transgenic C. elegans
The assay was set up by transferring to each well of a sterile 96-well
microplate, 80 μl (around 17–23worms) of age synchronized L1worms
(item2.5) in S-Complete containing 5mg/ml of E. coli OP50 and 1% (v/v)
LMWF-HAD50 or HMWF-HAD50 extracts (or DH2O for control). A min-
imumof 8wormswere prepared for each treatment and theplateswere
sealed with Glad Press‘n’Seal ® (Glad, Oakland, CA) and incubated at
20 °C. When the worms reached the L4 stage, they were transferred to
a 35-mm culture plate containing a solidiﬁed 2 ml layer of 1% Phytagel
(Sigma-Aldrich, St. Louis, MO). Worms were immobilized by adding
8 μl of 25 mM sodium azide solution in magnesium buffer and used
for direct in vivo ﬂuorescence imaging using a ﬂuorescence microscope
(Nikon SMZ1500with Ri1 CCD camera,Nikon, Japan). 12 replicateswith
a minimum of 120 worms were used per treatment. L4 worms were
randomly selected and the relativeﬂuorescence,with respect to control,
was quantiﬁed from the corrected total ﬂuorescence using the National
Institute of Health's ImageJ software (Iser & Wolkow, 2007).
2.7. Lifespan evaluation
The life span of the wild-type N2 strain was analyzed as described
by Solis and Petrascheck (2011). L1 synchronized adult worms in
S-complete medium (10–15 worms per 20 μl) containing 5 mg/ml
E. coli OP50, a mixture of penicillin-streptomycin 1% (v/v) was added.
An aliquot of the worm suspension (120 μl) was transferred to each
well of a 96-well plate, homogenized for 2 min and incubated for 45 h
at 20 °C until the animals reach the L4 stage. The animals were sterilized
by adding30 μl of a stock solution of 0.6mMﬂuorodeoxyuridine (FUDR)
to each well. After 8–12 h, LMWF-HAD50 (item 2.2) and their fractions
(PA, PB and PN) (item 2.3) were directly added at 1% (v/v), the plates
were sealed (Glad, Oakland, CA) and incubated at 20 °C. Every 5–
7 days, 5 μl of the E. coli OP50 (100 mg/ml) was added to each well.
The life span and survival rates were evaluated by scoring the alive
worms (swimming morphology) using a microscope (PARCO, Parco
Scientiﬁc Company—Westland, MI). Additionally, the mean, median
and maximum survival of worms were also calculated. Three replicates
were used per experiment with n N 300 worms per treatment.
2.8. Alzheimer's disease assay in transgenic C. elegans
The CL4176 strain containing a heat-sensitive mutation developed
to express human amyloid β1–42 (Aβ1–42) present in the muscle tissue
was maintained on NGM plates at 16 °C (Dostal, Roberts, & Link,
2010). Previous to the beginning of the experiment, C. elegans were
age synchronized at 16 °C (item 2.4). In order to stop the growth of
E. coli OP50, 50 μl of this mixture was spread and exposed to UV lightfor 2 min (Stratagene UV Stratalinker 2400, La Jolla, CA). After this, the
plates were incubated with treatments for 24 h at 23 °C (Sutphin &
Kaeberlein, 2009). L1 worms from F2 generation were transferred to
control or treatment plates and allowed to mature gravid adult stage
to lay eggs. After reaching the L3 stage, the incubation temperature
of the plates was increased from 16 °C to 25 °C, in order to induce the
expression of Aβ1–42. The evaluation of the mobility of worms was
started 18–20 h after increasing the incubation temperature in 2-hour
increments until all worms were paralyzed. Three replicates per exper-
iment were performed with a minimum of 75 worms were used. The
lack of touch response or head movements was used to deﬁne them
as paralyzed or dead. The time at which 50% of the worms were para-
lyzed or killed (PT50) was calculated based on the survival curves. Addi-
tionally, the mean, median and maximum survival of worms were also
calculated post heat shock treatment.
2.9. MPP+ induced Parkinson's disease assay in C. elegans
30 μl of L3 synchronized worms (approximately 17–23 worms) in
S-complete containing 5 mg/ml E. coli OP50 was mixed to 20 μl of
MPP+ (1.13 mg/ml DH2O) and 1% (v/v) of the treatments LMWF-
HAD50 and their fractions (PA, PB and PN) and the control (DH2O
instead of the treatment) were transferred to sterile 96-well plates
sealed with Glad Press‘n’Seal ® (Glad, Oakland, CA) and incubated at
20 °C. The mobility of the worms was counted in 12-hour intervals
and the total number of paralyzed worms was registered after 48 h. At
least 8 replicates per experiment with a minimal of 100 worms were
used. The lack of touch response and absence of pharyngeal pumping
was used to identify the paralyzed or dead worms (Braungart, Gerlach,
Riederer, Baumeister, & Hoener, 2004).
2.10. Statistical analyses
Resultswereexpressedasmean±standarddeviation.One-wayANOVA
wasusedtodeterminestatisticalsigniﬁcance(pb0.05)forinvivostudiesof
geneexpressionandfortheassayofMPP+inducedParkinson'sdisease.For
Alzheimer's disease assay, the survival differenceswere tested for signiﬁ-
cance (pb 0.001)by theBreslow–Gehan–Wilcoxon test. For the life span
assay, theKaplan–Meiermethodwasusedtocomparethelifespansurvival
curves and the survival differenceswere tested for signiﬁcance (pb 0.05)
using theLog rank test (Mantel Cox). Both testsusedGraphPadPrismsoft-
ware6.0 (GraphPadSoftware, Inc., SanDiego,CA).
3. Results
3.1. The effect of dried camu-camu on genes relevant to aging and
neurodegeneration
Treatment with LMWF-HAD50 (1% v/v) resulted in a signiﬁcant
downregulation in the expression of daf-16 transcription factor
(Fig. 1A), whereas treatment with HMWF-HAD50 had no change on
the expression of the fork-head transcription factor daf-16 compared
to the control. Expression of the mitochondrial superoxide dismutase
sod-3 gene was upregulated 3-fold relative to control in response
to treatment with LMWF-HAD50, but did not have any effect on in
response to treatment with HMWF-HAD50 (Fig. 1B). The expression
of extra cellular superoxide dismutase sod-4 gene was also upregulated
signiﬁcantly both in response to treatment with LMWF-HAD50 and
HMWF-HAD50 (Fig. 1C). In response to treatment with 1% (v/v) of
camu-camu extracts, the expression of catalases (ctl-1, ctl-2, ctl-3) was
upregulated relative to control both in response to treatment with
LMWF-HAD50 and HMWF-HAD50 (Fig. 1D).The expression of nuclear
factor-erythroid-2 related factor-2 (Nrf2) transcription factor or skn-1
that regulates the expression of several antioxidant response genes
was upregulated in response to treatments with both LMWF-
HAD50 and HMWF-HAD50 (Fig. 1E). The expression of glutathione-
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Fig. 1. Relative change (% of control) in expression of (A) daf-16 (B) sod-3 (C) sod-4 (D) ctl-1+ ctl-2+ ctl-3 (E) skn-1 (F) gst-4 in transgenic C. elegansworms (GR1352, CF1553, BC13632,
GA800, LG326 and CL2166) fed on: control: [NGM]; LMWF-HAD50 [NGM + 1% (v/v) LMWF-HAD50]; HMWF-HAD50 [NGM + 1% (v/v) HMWF-HAD50]. E. coli OP50 (5 mg/ml);
n N 100; * p b 0.05 (ANOVA).
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in response to treatment with LMWF-HAD50, but again did not
change in response to treatment with HMWF-HAD50 (Fig. 1F).
Overall, treatmentwithLMWF-HAD50appeared to result inamore ro-
bustantioxidantresponseandenhancedprotectionagainstoxidativestress,
and therefore,wasselected for further fractionation(PA,PBandPN). These
fractionswereusedtoevaluatetheirabilitytoextendlifespan(item3.2)and
abrogateexperimentally inducedneurodegeneration(3.3) inC. elegans.
3.2. Effect on the life span of wild type C. elegans
Fig. 2 presents the survival curves ofwild typeC. elegans (N2) treated
with the lowmolecular weight extracts of HAD50 and its PA, PB and PN
fractions, respectively. The effect of treatment on the life span of wild
type (N2) C. elegans was determined using Kaplan–Meier survivalanalysis with Log-rank signiﬁcance test. The median life span of
C. elegans in control group (no treatment) was 15 d (Table 2). The me-
dian life span of C. elegans treated with LMWF-HAD50 increased signif-
icantly by 20% to 19 d (p b 0.001) compared to control. Among all the
fractions, treatment with PB-HAD-50 (Table 2) also resulted in a signif-
icant extension in life span of C. elegans to 19 d relative to control. Treat-
mentwith other fractions (PA-HAD-50 and PN-HAD-50) only increased
the life span of C. elegans by 13% relative to control.
3.3. Extracts of dried camu-camu residue ameliorate experimentally
induced neurodegeneration in C. elegans
3.3.1. Alzheimer's disease
The mobility curves for the CL4176 strain after the Aß1–42 induction
of muscular paralysis at 25 °C are shown in Fig. 3. In control worms,
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Fig. 2. Kaplan–Meier survival plots of wild type (N2) C. elegans worms treated with low
molecular weight extract of HAD50 (LMWF-HAD50) and fractions polar acid (PA), polar
basic (PB) and polar neutral (PN). (□) Control: [NGM]; (◊) LMWF-HAD50: [NGM +
1% (v/v) LMWF-HAD50]; ( ) PA-HAD50: [NGM+ 1% (v/v) PA-HAD50]; (✳) PB-HAD50:
[NGM +1% (v/v) PB-HAD50]; (♦) PN-HAD50: [NGM + 1% (v/v) PN-HAD50]. E. coli
OP50 (5 mg/ml); n N 300.
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Fig. 3. Kaplan–Meier mobility plots of transgenic C. elegansworms (CL4176) treated with
low molecular weight extract of HAD50 (LMWF-HAD50) and fractions polar acid (PA),
polar basic (PB) and polar neutral (PN) 20 h post Aß1–42 induction of muscular paralysis
at 25 °C. (■) Control: [NGM]; (♦) LMWF-HAD50: [NGM + 1% (v/v) LMWF-HAD50];
(▲) PA-HAD50: [NGM + 1% (v/v) PA-HAD50]; (●) PB-HAD50: [NGM +1% (v/v) PB-
HAD50]; (▼) PN-HAD50: [NGM+ 1% (v/v) PN-HAD50]. E. coli OP50 (5 mg/ml); n N 75.
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or dead (PT50) (Table 3). Treatment with LMWF-HAD-50 signiﬁcantly
delayed the Aß1–42 induced paralysis by 20.3% (PT50 = 34.3 h). Treat-
ment with all fractions also resulted (Table 3) in a signiﬁcant delay
(p b 0.0001) in the induction of paralysis by 14.4% for PA-HAD50
(PT50 = 32.6 h); 8.7% for PB-HAD50 (PT50 = 31.0 h) and 9.4% for PN-
HAD50 (PT50 = 31.2 h).
3.3.2. Parkinson's disease
The effect of camu-camu extracts on ameliorating Parkinson's
disease like symptoms were evaluated in wild type (N2) C. elegans by
inducing the dopaminergic neurodegeneration using 1-methyl-4-
phenylpyridinium (MPP+). MPP+ is a metabolite formed from 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and is selectively
toxic to dopaminergic neurons (Braungart et al., 2004). In C. elegans
treatedwithMPP+alone, 55.5% of N2wild typewormswere complete-
ly paralyzed after 48 h (Fig. 4). In worms that were exposed to MPP+,
but co-treated with LMWF-HAD50, only 39.9% of the worms were
paralyzed after 48 h. Among the fractions, treatmentwith PA-HAD50 re-
sulted in only 34.2% worms being paralyzed, treatment with PB-HAD50
and PN-HAD50 did not confer a signiﬁcant neuroprotection against
MPP+ induced neurotoxicity in C. elegans relative to control.
4. Discussion
Recent research has shown that camu-camu pulp and residue are
promising sources of multifunctional phytochemicals such as natural an-
tioxidants, ﬂavonoids and vitamin C (Azevêdo et al., 2014; Fujita et al.,Table 2
Life span (mean, median and maximum number of days) of wild type (N2) C. elegans
worms treatedwith lowmolecular weight extract of HAD50 (LMWF-HAD50) and fractions
polar acid (PA), polar basic (PB) and polar neutral (PN).
Control LMWF-HAD50 PA-HAD50 PB-HAD50 PN-HAD50
Mean (d) 18.1 19.3 19.8 19.1 17.9
Median (d) 15.0 19.0 19.0 17.0 17.0
Maximum (d) 29.5 29.3 29.3 29.9 30.4
p (relative to
control)
– b0.001 b0.001 b0.001 b0.001
Control: [NGM]; LMWF-HAD50: [NGM+ 1% (v/v) LMWF-HAD50]; PA-HAD50: [NGM+
1% (v/v) PA-HAD50]; PB-HAD50: [NGM + 1% (v/v) PB-HAD50]; PN-HAD50: [NGM +
1% (v/v) PN-HAD50]. E. coli OP50 (5 mg/ml); n N 300. The data were processed using the
Kaplan–Meir survival analysis.2013; Chirinos, Galarza, Betalleluz-Pallardel, Pedreschi, & Campos,
2010). However, few studies have investigated the in vivo biological ef-
fects of camu-camu and its derivatives (Gonçalves et al., 2014). We have
previously shown that HAD50 camu-camu samples are natural sources
of important ﬂavonoids, including quercetin (Azevêdo et al., 2014), and
therefore, this group was selected to investigate its effect on modulation
of gene expression relevant to oxidative stress response signaling path-
ways and neurodegeneration in C. elegans. Additionally, we also looked
the effect of the different fractions of HAD50 camu-camuextracts on ame-
liorating experimentally induced neurodegeneration in C. elegansmodel.
We initially fractionated the HAD50 camu-camu into LMWF and
HMWF and investigated their effect on modulation of genes relevant to
redox response signaling in transgenic C. elegans. Our results suggested
that, treatment with LMWF-HAD50 caused a down regulation in the ex-
pression of daf-16 in C. elegans, an important transcription factor regulat-
ing the expression of several genes involved in nutrient, oxidant and
stress response including, the iron/manganese superoxide dismutase
(SOD-3) in mitochondria and cytoplasmic catalases (CTL-1; CTL-2; CTL-
3) (Wen, Gao, & Qin, 2013). On the other hand, treatment with 1% (v/v)
HMWF-HAD50 did not have any effect on the expression of daf-16.
However, the expression of SOD-3 which is under direct transcrip-
tional regulation of daf-16, was signiﬁcantly upregulated in response
to treatment with LMWF-HAD50, but did not change in response to
treatmentwith HMWF-HAD50. Also, the expression of the extracellular
copper/zinc superoxide dismutase was signiﬁcantly upregulated in
response to treatment with both LMWF-HAD50 and HMWF-HAD50.Survival (mean, median, maximum number of hours and PT50) of C. elegans worms
(CL4176) treated with lowmolecular weight extract of HAD50 (LMWF-HAD50) and frac-
tions polar acid (PA), polar basic (PB) and polar neutral (PN) 20 h post Aß1–42 induction of
muscular paralysis at 25 °C.
Control LMWF-HAD50 PA-HAD50 PB-HAD50 PN-HAD50
Mean (h) 29.1 34.5 33.7 32.4 32.0
Median (h) 30.1 36.0 34.2 32.1 32.0
Maximum (h) 31.9 36.0 36.0 36.0 34.1
PT50 (h) 28.5 34.3 32.6 31.0 31.2
p (relative to
control)
– b0.001 b0.0001 b0.0001 b0.0001
Control: [NGM]; LMWF-HAD50: [NGM+ 1% (v/v) LMWF-HAD50]; PA-HAD50: [NGM+
1% (v/v) PA-HAD50]; PB-HAD50: [NGM +1% (v/v) PB-HAD50]; PN-HAD50: [NGM +
1% (v/v) PN-HAD50]. [E. coli OP50 (5 mg/ml); n N 75. The data were processed using the
Breslow–Gehan–Wilcoxon test. PT50: The time atwhich 50% of thewormswere paralyzed
or killed post temperature upshift.
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Fig. 4. Mobility scores of wild type (N2) C. elegans worms treated with low molecular
weight extract of HAD50 (LMWF-HAD50) and fractions polar acid (PA), polar basic (PB)
and polar neutral (PN) 48 h postMPP+ (1.13mg/ml) induced dopaminergic neurodegen-
eration and paralysis. Control: [NGM]; LMWF-HAD50: [NGM+ 1% (v/v) LMWF-HAD50];
PA-HAD50: [NGM + 1% (v/v) PA-HAD50]; PB-HAD50: [NGM + 1% (v/v) PB-HAD50];
PN-HAD50: [NGM + 1% (v/v) PN-HAD50]. E. coli OP50 (5 mg/ml); n N 100; * p b 0.05
(ANOVA).
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also signiﬁcantly upregulated in response to treatment with LMWF-
HAD50 and HMWF-HAD50, suggesting that though the expression of
daf-16 was downregulated or did not change in response to treatment
with camu-camu extracts, daf-16 was transcriptionally more active
relative to control and conferred more resistance against oxidative
stress (Kampkötter et al., 2008), more so with LMWF-HAD50 than
with HMWF-HAD50.
These results are similar to the observations made in a similar study
investigating the anti-aging role of polydatin (a natural resveratrol
glycoside) in C. elegans, where an DAF-16 expression was found to
be delineated from the expression of SOD-3 and CTL (CTL-1; CTL-2;
CTL-3) expression (Wen et al., 2013). The SKN-1 is a transcription factor
that, when active, translocates into the nucleus and binds to the anti-
oxidant responsive element (ARE) to activate the expression of the
putative phase-II detoxiﬁcation enzymes (An et al., 2005), including
glutathione-s-transferase enzyme, which was upregulated in response
to treatment with both LMWF-HAD50 and HMWF-HAD50. However,
the expression of gst-4 was downregulated in response to treatment
with LMWF-HAD50 and remained unchanged with HMWF-HAD50
suggesting a possible induction of a normoxic environment in response
to treatment with camu-camu extracts (Wang et al., 2006), similar to a
recent study where açaí extracts did not affect the expression of gst-4
in C. elegans (Bonomo et al., 2014). We have recently shown that the
experimental group HAD50 contains several bioactive compounds
including quercetin, (+)-catechin, myricetin, ellagic and syringic acids
(Azevêdo et al., 2014). Quercetin, a low molecular weight ﬂavonoid,
was shown to substantially increase C. elegans life span (Saul, Pietsch,
Menzel, Stürzenbaum, & Steinberg, 2009; Kampkötter et al., 2008;
Surco-Laos et al., 2011) that was dependent on FOXO transcription
factor DAF-16. Additionally, treatment with quercetin also improved
stress resistance and increased nuclear translocation of DAF-16 in
C. elegans (Kampkötter et al., 2008). Similarly, treatment with the ﬂavo-
nol catechin resulted in a dose-dependent increase in C. elegans life span
via the modulation of several stress response genes including daf-16,
sod-3, and skn-1 (Saul et al., 2009; Zhang, Jie, Zhang, & Zhao, 2009)
and may explain some of the results observed here.
Mitochondrial dysfunction, oxidative stress and intra and extracellu-
lar accumulation of misfolded or damaged proteins have been linked
to the ethiopathology of aging and neurodegenerative diseases (Cohen
& Dillin, 2008; Radak, Zhao, Goto, & Koltai, 2011; Jayasena, Poljak,Smythe, Münch, & Sachved, 2013). Since, overall, LMWF-HAD50 had a
more robust effect on resistance against oxidative stress in C. elegans,
we decided to further fractionate this extract and study its effect on ex-
tension of life span and on experimentally induced neurodegeneration
in C. elegans. In response to dietary supplementation with LMWF-
HAD50, the life span of the model increased by 20% relative to the
control. Moreover, this increase in life span appeared to be due to the
bioactive compounds in the polar basic fraction (PB-HAD50) fraction,
which also increased the life span of C. elegans by 20%, whereas the
other fractions were only able to extend the life span by 13% relative to
control. Wilson et al. (2006) have shown that the proanthocyanidin-
rich fraction of blueberries were especially effective in enhancing
the longevity in C. elegans. We have recently demonstrated that
camu-camu HAD50 extracts have signiﬁcantly higher levels of pro-
anthocyanidins (Azevêdo et al., 2014) and may be responsible for the
signiﬁcant extension in life span with LMWF-HAD50, and especially
with PB-HAD50 fraction. In addition, the heat-shock induced aggrega-
tion of Aβ1–42 peptide and resultant paralysis was also signiﬁcantly de-
layed in C. elegansmodel in response to treatment with LMWF-HAD50,
which delayed the induction of paralysis by 20.3% relative to control.
Surprisingly, neither one of the fractions (PA-HAD50; PB-HAD50 or
PN-HAD50) was as effective as LMWF-HAD50 in delaying the Aβ1–42
induced paralysis, suggesting a potential synergistic interaction be-
tween the bioactive components in the different fractions.
The transgenic model of C. elegans for Alzheimer's disease used
in our study speciﬁcally measures the intracellular aggregation of
the Aβ1–42 peptide in muscle tissues. Increased life span and delayed
Aβ1–42 aggregation induced paralysis in C. elegans upon dietary supple-
mentation with camu-camu is similar to observations made with caf-
feine, ginkgo biloba and with curcumin recently (Dostal et al., 2010;
Wu et al., 2006). It was suggested that these bioactive compounds,
due to their spatial conﬁguration,may facilitate an increased thermody-
namically stable interaction with amyloidogenic proteins to prevent
their oligomerization, and thus aggregation (Wu et al., 2006).
TheMPP+ induced neurotoxicity is a popular system to study PD in
vertebrate and invertebrate models, especially C. elegans (Braungart
et al., 2004). In our study, treatment with LMWF-HAD50 resulted in
a 15.6% reduction in MPP+ induced paralysis relative to the control.
It appeared that the neuroprotective effect of LMWF-HAD50 was
concentrated mostly in the polar acidic (PA-HAD50) fraction, which re-
duced the MPP+ induced paralysis by 21.3% relative to control. MPP+
(1-methyl-4-phenylpyridinium) is internalized by the pre-synaptic do-
paminergic cell where it inhibits themitochondrial complex-I protein of
the electron transport chain and causes oxidative stress, ATP depletion
and mitochondrial dysfunction and dopaminergic neuronal cell death
for Parkinson's disease (PD) like symptoms (Chakraborty et al., 2013).
It is possible that the protection against MPP+ induced neurotoxicity
upon treatment with LMWF-HAD50 and PA-HAD50 could be due to
abrogation of oxidative stress and mitochondrial dysfunction via the
enhanced activation of oxidative stress response, speciﬁcally via the
increased expression of SOD-3 and catalase genes as explained above.
5. Conclusion
We have recently shown that hot air dried camu-camu residue is
an excellent source of bioactive compounds including ascorbic acid,
proanthocyanidins, ellagic acid, myricetin and quercetin (Azevêdo
et al., 2014). In this study, we have demonstrated for the ﬁrst time
that the camu-camu residue, especially the low molecular weight frac-
tion was able to increase the expression of critical antioxidant genes
and provide increased resistance against oxidative stress in vivo in
C. elegans. Our results also show that treatment with camu-camu
extracts signiﬁcantly extended the life span of C. elegans by 20%, an
effect that appeared to be mostly due to the polar basic bioactive com-
pounds in the extracts. The camu-camu residue extracts were also
able to signiﬁcantly reduce the Aβ1–42 aggregation induced paralysis
141J.C.S. Azevêdo et al. / Food Research International 73 (2015) 135–141in the Alzheimer's disease model. Our results suggest that this effect
was due to a synergistic interaction between the various lowmolecular
bioactive fractions in the camu-camu residue. In the MPP+ induced
oxidative dopaminergic neurotoxicity model for Parkinson's disease
in C. elegans, treatment with low molecular weight fraction of camu-
camu residue resulted in signiﬁcant abrogation in neurotoxicity. It is
inferred that this effectwasmostly due to the polar acidic lowmolecular
weight bioactive fractions. Taken together, here it is shown that dried
camu-camu residue is a bioactive-rich product with health-relevant
potential to be used as a functional food ingredient and merits further
investigation.
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